A novel chemiluminescent immunoassay for detection of Toxoplasma gondii IgG in human sera
Keywords: CLIA; Serological detection; Chemiluminescence; Acridinium esters;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome
Keywords: APS; antiphospholipid syndrome; aPL; antiphospholipid; LA; lupus anticoagulant; aCL; anticardiolipin; anti-β2GPI; anti-β2 Glycoprotein I antibodies; PAPS; primary antiphospholipid syndrome; DI; Domain I; anti-DI; anti-Domain I; ELISA; enzyme-linked immu
Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age
Keywords: anti-HBs; antibody against hepatitis B surface antigen; ATP; according to protocol; CI; confidence interval; CLIA; chemiluminescence immunoassay; DTPa-HBV-IPV/Hib; hexavalent diphtheria-tetanus-pertussis-hepatitis B-inactivated poliomyelitis and Hae
Quantitative analytical method to evaluate the metabolism of vitamin D
Keywords: 1,25(OH)2D; 1,25-dihydroxyvitamin D; 24,25(OH)3D; 24,25-dihydroxyvitamin D; 25(OH)D; 25-hydroxyvitamin D; ACE; automatic cartridge exchange; CLIA; chemiluminescence immunoassays; CPB; competitive protein binding assay; DEQAS; vitamin D external quality as
HDL particle number measured on the Vantera®, the first clinical NMR analyzer
Keywords: NMR; nuclear magnetic resonance; HDL; high-density lipoprotein; HDL-P; HDL particle number; HDL; high-density lipoprotein; CVD; cardiovascular disease; HDL-C; high-density lipoprotein-cholesterol; LDL-C; low-density lipoprotein-cholesterol; VLDL; very
Vitamin D and parathyroid hormone status in a representative population living in Macau, China
Keywords: 25OHD; 25-hydroxyvitamin D; PTH; parathyroid hormone; Ca; calcium; PA; physical activity; IPAQ-S; International Physical Activity Questionnaire short version; OR; odds ratios; 95% CI; 95% confidence intervals; SD; standard deviation; yrs; years; mins; min
Study of blood collection and sample preparation for analysis of vitamin D and its metabolites by liquid chromatography-tandem mass spectrometry
Keywords: 1,25(OH)2D; 1,25-dihydroxyvitamin D; 24,25(OH)2D; 24,25-dihydroxyvitamin D; 25(OH)D; 25-hydroxyvitamin D; ACE; automatic cartridge exchange; CLIA; chemiluminescence immunoassays; CPB; competitive protein binding assay; ESI+; electrospray ionization in pos
A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults
Keywords: Staphylococcus aureus; Vaccine; Functional antibodies; Capsule proteins; Clinicaltrials.gov Identifier. NCT01018641; AE; adverse event; ClfA; clumping factor A; cLIA; competitive Luminex® immunoassay; CP; capsular polysaccharide; CP5; capsular polysaccha
Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial
Keywords: cLIA; Merck competitive Luminex immunoassay; EIA; enzyme immunoassay; GMT; geometric mean titre; mMU; milli-Merck units; NT100; 100% neutralization endpoint; NT90; 90% neutralization endpoint; NTpartial; partial neutralization endpoint; PsV NAb; pseudovir
NMR measurement of LDL particle number using the Vantera® Clinical Analyzer
Keywords: NMR; Nuclear magnetic resonance; LDL-P; Low density lipoprotein particle number; LDL-C; Low density lipoprotein-cholesterol; CLSI; Clinical Laboratory Standards Institute; CV; Coefficient of variation; CVD; Cardiovascular disease; LDL; Low density lipopro
DNA Testing and Molecular Screening for Colon Cancer
Keywords: Genetics; Heredity; Colon Cancer; Fecal DNA Test; Polyposis; CLIA; Clinical Laboratories Improvement Act; CRC; colorectal cancer; EGFR; epidermal growth factor receptor; FIT; fecal immunochemical test; FOBT; fecal occult blood test; MMR; mismatch repair;
Development and validation of an LC-MS/MS based method for quantification of 25 hydroxyvitamin D2 and 25 hydroxyvitamin D3 in human serum and plasma
Keywords: 25(OH)D; 25-hydroxyvitamin D; 25(OH)D2; 25-hydroxyvitamin D2; 25(OH)D3; 25-hydroxyvitamin D3; 1,25(OH)2D; 1,25-dihydroxyvitamin D; DBP; vitamin D binding protein; RIA; radioimmunoassay; ELISA; enzyme-linked immunosorbent assay; HPLC; high performance liqu
An assessment of 25-hydroxyvitamin D measurements in comparability studies conducted by the Vitamin D Metabolites Quality Assurance Program
Keywords: 3-epi-25(OH)D3; 3-epi-25-hydroxyvitamin D3; 25(OH)D2; 25-hydroxyvitamin D2; 25(OH)D3; 25-hydroxyvitamin D3; U95; 95% confidence limit; ABVD; Accuracy-Based Vitamin D; ALTM; all-laboratory trimmed mean; CLIA; chemiluminescence immunoassay; EIA; enzyme immu
Practical, ethical and regulatory considerations for the evolving medical and research genomics landscape
Keywords: CLIA, Clinical Laboratory Improvements Amendments; NGS, Next generation sequencing; WGS, whole-genome sequencingGenomics; Whole genome sequencing; Ethics; Regulation; CLIA; Exome; Genetic testing
Impact of CYP3A5 genetic polymorphism on cross-reactivity in tacrolimus chemiluminescent immunoassay in kidney transplant recipients
Keywords: CYP; cytochrome P450; CLIA; chemiluminescent immunoassay; C12; blood level at 12Â h; LC-MS/MS; liquid chromatography-tandem mass spectrometry; Tacrolimus; Chemiluminescent immunoassay; CYP3A5; Cross-reactivity; Kidney transplantation;
Prolactin and thyroid hormone levels are associated with suicide attempts in psychiatric patients
Keywords: HPT; hypothalamic-pituitary-thyroid; TSH; thyroid stimulating hormone; TRH; thyrotropin-releasing hormone; PRL; prolactin; d-FEN; d-fenfluramine test; 5-HT; 5-hydroxytryptamine; HPA; hypothalamic-pituitary-adrenal; ED; Emergency Department; DSM-IV
Sexual dysfunction and hyperprolactinemia in Japanese schizophrenic patients taking antipsychotics
Keywords: ASEX; Arizona Sexual Experience Scale; CLIA; chemiluminescence immunoassay; CP; chlorpromazine; CSFQ; Changes in Sexual Functioning Questionnaire; NSFQ; Nagoya Sexual Function Questionnaire; PRSexDQ-SALSEX; Psychometric Properties of the Psychotropic-Rela
A rapid and sensitive chemiluminescence immunoassay based on magnetic particles for squamous cell carcinoma antigen in human serum
Keywords: CLIA; chemiluminescence immunoassay; SCCa; squamous cell carcinoma antigen; FITC; fluorescein isothiocyanate; ABEI; N-(aminobutyl)-N-(ethylisoluminol); CL; chemiluminescence; MPs; magnetic particles; BSA; bovine serum albumin; EDC; 1-ethyl-3-3(3-dimethyla
Suitability of chemiluminescent enzyme immunoassay for the measurement of blood tacrolimus concentrations in rheumatoid arthritis
Keywords: Tacrolimus; 13-O-Demethylated tacrolimus; 31-O-Demethylated tacrolimus; CLIA; HPLC-MS/MS; Rheumatoid arthritis; Renal transplantation; Overestimation; Cross-reactivity; ARCHITECT
Translating Research Discoveries Into Clinical Tests
Keywords: Genetic tests; clinical testing; CLIA; test validation;
Prevalence of serum antibodies to TORCH among women before pregnancy or in the early period of pregnancy in Beijing
Keywords: TOX, Toxoplasma gondii; RV, Rubella virus; CMV, Cytomegalovirus; HSV, Herpes simplex virus; TORCH, Acronym for TOX, RV, CMV and HSVTORCH; CLIA; Methodology; Infective rate
Analysis: Secretary's Advisory Committee on Genetics, Health, and Society Report falls short
Keywords: SACGHS; Secretary's Advisory Committee on Genetics Health and Society; Molecular diagnostics; Genetic testing; Pharmacogenetics; EGAPP; HER2; Laboratory regulation; CLIA; Food and drug administration; FDA; Proficiency testing; Laboratory developed tests;
An evaluation of clinical accuracy of the EasyTouch blood uric acid self-monitoring system
Keywords: Uric acid; Self-monitoring system; Linear regression; CLIA;
Serological diagnosis of infectious mononucleosis by chemiluminescent immunoassay using capsid antigen p18 of Epstein-Barr virus
Keywords: CLIA; Infectious mononucleosis; EBV VCA IgM; Methodology; Diagnostic performance;
Analytical and clinical performance of an automated chemiluminescent immunoassay for direct renin measurement: comparison with PRA and aldosterone assays
Keywords: Chemiluminescent immunoassay; Direct renin; Plasma renin activity; Aldosterone; Heart failure; Chemiluminescent immuno essai; Rénine directe; Activité plasmatique de la rénine; Aldostérone; Décompensation cardiaque; ACE; angiotensin converting enzyme
Human tumor cell lysates as a protein source for the detection of cancer antigen-specific humoral immunity
Keywords: CDER; Center for Drug Evaluation and Research; CLIA; Clinical Laboratory Improvement Act; CV; coefficient of variation; ELISA; enzyme-linked immunosorbent assay; FCS; fetal calf serum; HRP; horseradish peroxidase; NGS; normal goat serum; OD; optical densi
Clinical and genetic issues in familial dilated cardiomyopathy
Keywords: AD; autosomal dominant; CK; creatine kinase; CLIA; Clinical Laboratories Improvement Act; DCM; dilated cardiomyopathy; ECG; electrocardiography; FDC; familial dilated cardiomyopathy; HCM; hypertrophic cardiomyopathy; HF; heart failure; IDC; idiopathic dil